Tackling Early Phase Development with First-In-Human Study Solutions

Overview


Tackling-Early-Phase-Development-with-First-In-Human-Study-Solutions.png

Bringing new drugs to market, from lead candidate selection through preclinical testing, to clinical proof of concept, is a complex, time-consuming, and costly process. At Altasciences, we simplify the journey for you, and deliver a stress-free experience with a turnkey first-in-human (FIH) solution.

Our integrated solution provides seamless processes to deliver quality with speed and ease.

In this edition of The Altascientist, we walk you through the key aspects of FIH trial designs with a case study to demonstrate.

This content is provided by Altasciences, and any views and opinions expressed do not necessarily reflect those of Outsourcing-Pharma.com

Download Now


Related Resources

Manufacturing Drugs with Highly Potent APIs

Manufacturing Drugs with Highly Potent APIs

Content provided by Altasciences

White Paper

In this issue of The Altascientist, we examine the critical considerations for the safe and compliant manufacture of drugs with highly potent APIs (HPAPIs), including: a review of the relevant guidance HPAPI classification systems safety processes...

CNS Drug Development―One Partner From Discovery to Market

CNS Drug Development―One Partner From Discovery to Market

Content provided by Altasciences

White Paper

As a leading partner in central nervous system (CNS) drug development, Altasciences’ in-house preclinical, clinical, bioanalytical, and manufacturing teams have decades of experience formulating, testing, and manufacturing pharmaceutical products that...

Supplier Info Centre

Altasciences.jpg

For more product information visit Altasciences.